Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Orwin John A Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 4 Orwin John A (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
05/19/2023 4 Orwin John A (Director) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Granted 4,500 shares @ $0
Granted 13,500 options to buy @ $17.11, valued at $231k
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/20/2022 4 Orwin John A (President & CEO) has filed a Form 4 on Atreca, Inc.
Txns: Sold 20,908 shares @ $1.7752, valued at $37.1k
06/15/2022 4 Orwin John A (President & CEO) has filed a Form 4 on Atreca, Inc.
Txns: Granted 260,000 options to buy @ $1.845, valued at $479.7k
Disposed/sold 260,000 options to buy @ $13.97, valued at $3.6M
Granted 241,000 options to buy @ $1.845, valued at $444.6k
Disposed/sold 241,000 options to buy @ $22.07, valued at $5.3M
Granted 148,754 options to buy @ $1.845, valued at $274.5k
Disposed/sold 148,754 options to buy @ $10.02, valued at $1.5M
Granted 58,995 options to buy @ $1.845, valued at $108.8k
Disposed/sold 58,995 options to buy @ $10.02, valued at $591.1k
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2021 4 Orwin John A (President & CEO) has filed a Form 4 on Atreca, Inc.
Txns: Granted 260,000 options to buy @ $3.18, valued at $826.8k
09/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/29/2021 4 Orwin John A (President & CEO) has filed a Form 4 on Atreca, Inc.
Txns: Granted 260,000 options to buy @ $13.97, valued at $3.6M
05/19/2020 4 Orwin John A (Director) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 3,000 shares @ $0
Granted 9,000 options to buy @ $15.43, valued at $138.9k
05/19/2020 4 Orwin John A (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 1,335 shares @ $0
Granted 3,171 options to buy @ $160.33, valued at $508.4k
03/19/2020 4 Orwin John A (President & CEO) has filed a Form 4 on Atreca, Inc.
Txns: Bought 6,000 shares @ $12.79, valued at $76.7k
02/28/2020 4 Orwin John A (President & CEO) has filed a Form 4 on Atreca, Inc.
Txns: Granted 241,000 options to buy @ $22.07, valued at $5.3M
07/30/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/22/2019 4 Orwin John A (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 2,963 shares @ $0
Granted 7,038 options to buy @ $64.38, valued at $453.1k
05/10/2019 4 Orwin John A (Director) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 2,000 shares @ $0
Granted 8,000 options to buy @ $17.94, valued at $143.5k
10/29/2018 4 Orwin John A (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Granted 25,000 options to buy @ $0
Granted 5,000 restricted stock units @ $0
Exercised 5,000 restricted stock units @ $0
05/22/2018 4 Orwin John A (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 3,700 shares @ $0
Granted 9,260 options to buy @ $56.77, valued at $525.7k
05/11/2018 4 Orwin John A (Director) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 2,500 shares @ $0
Granted 10,000 options to buy @ $26.52, valued at $265.2k
10/27/2017 4 Orwin John A (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Exercised 5,000 shares @ $10.47, valued at $52.4k
Granted 25,000 options to buy @ $10.47, valued at $261.8k
Granted 5,000 restricted stock units @ $0
Exercised 5,000 restricted stock units @ $0
05/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2017 4 Orwin John A (Director) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 4,375 shares @ $0
Granted 17,500 options to buy @ $17.53, valued at $306.8k
10/31/2016 4 Orwin John A (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Exercised 5,000 shares @ $5.83, valued at $29.2k
Granted 5,000 restricted stock units @ $0
Granted 25,000 options to buy @ $5.95, valued at $148.8k
Exercised 5,000 restricted stock units @ $0
09/02/2016 4 Orwin John A (President & CEO) has filed a Form 4 on Relypsa Inc
Txns: Granted 11,250 shares @ $0
Unknown transaction of 10,142 shares @ $32, valued at $324.5k
Disposed/sold 55,000 shares @ $32, valued at $1.8M
Granted 45,000 options to buy @ $18.87, valued at $849.2k
Disposed/sold 67,500 options to buy @ $18.87, valued at $1.3M
Disposed/sold 727,877 options to buy @ $7.4, valued at $5.4M
Disposed/sold 94,500 options to buy @ $27.21, valued at $2.6M
Disposed/sold 105,000 options to buy @ $28.38, valued at $3M
08/17/2016 4 Orwin John A (President & CEO) has filed a Form 4 on Relypsa Inc
Txns: Paid exercise price by delivering 3,994 shares @ $31.89, valued at $127.4k
06/07/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/24/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/17/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/24/2013 4 Orwin John A (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns: Granted 25,000 options to buy @ $5.6, valued at $140k
06/28/2013 4 Orwin John A (Director) has filed a Form 4 on AFFYMAX INC
Txns: Paid exercise price by delivering 16,334 shares @ $1.0225, valued at $16.7k
Gifted 15,000 shares @ $0
12/04/2012 4 Orwin John A (CEO) has filed a Form 4 on AFFYMAX INC
Txns: Sold 15,798 shares @ $24.22, valued at $382.6k
Exercised 12,498 options to buy @ $6.9, valued at $86.2k
Exercised 3,300 options to buy @ $5.83, valued at $19.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy